12 August 2024

What is PrEP and how is it revolutionising HIV prevention?

HIV

In the fight against HIV and AIDS, a powerful weapon has been developed in recent years that has forever changed the way we fight this pandemic: PrEP. Pre-exposure prophylaxis, better known as PrEP, is a preventive treatment that protects HIV-negative individuals from the virus before they are exposed to it. This approach has already had a significant impact on public health and offers new hope for a world without HIV. But what exactly is PrEP and how is it contributing to this revolution? Let's explore the power and potential of this pioneering prevention method.

The science behind PrEP

PrEP is a drug treatment that involves people who are HIV-negative but at high risk of infection taking a pill (usually Truvada or Descovy) daily. The active ingredients in these pills, tenofovir and emtricitabine, block the enzyme that HIV needs to multiply in the body. This gives the immune system a chance to fight the virus before it can settle and multiply. When taken consistently and correctly, PrEP can reduce the risk of HIV infection through sex by more than 99%.

The powerful impact of PrEP

The introduction of PrEP has dramatically changed HIV prevention, especially in communities hardest hit by the virus. It offers individuals a proactive way to protect their health and has contributed to a significant drop in the number of new HIV infections in countries where it is widely available. Research shows that PrEP is particularly effective for men who have sex with men (MSM), transgender individuals and people with a seropositive partner.

One of the biggest benefits of PrEP is the control and autonomy it offers to individuals. It allows them to manage their own health without being completely dependent on external factors, such as the use of condoms by partners. This aspect of self-determination is crucial for many people, especially in situations where it is difficult to negotiate condom use.

The innovative injectable version

While the oral form of PrEP has already changed many lives, an innovative step has recently been taken with the development of an injectable version of PrEP. Cabotegravir, the active ingredient in the injectable form, is a long-acting drug that can be administered every two months. This development is a gamechanger for people who have difficulty taking a pill daily or who would benefit from a less frequent dosing schedule.
The injectable form offers several advantages:

  1. Ease of use: No daily reminder needed to take a pill, which is especially convenient for people with busy lives or limited access to care.
  2. Discreet prevention: For those who do not want their partners or housemates to know about their HIV prevention, the injectable form offers a subtle solution.
  3. Better adherence: Studies have shown that adherence is higher with injectable PrEP, as users do not have to take a pill every day.

The future of HIV prevention

The introduction of PrEP and the development of an injectable version mark a turning point in the fight against HIV. PrEP offers not only effective protection but also a new perspective on HIV prevention in which stigma and fear are less prevalent. With continued advances in medical technology and access to care, a world without new HIV infections is getting ever closer.

Despite these advances, it remains crucial to promote awareness and education around HIV and PrEP. Access to PrEP should be extended to all at-risk groups, regardless of their geographical or socioeconomic background. By breaking down barriers and providing everyone with access to this preventive treatment, we can further turn the tide of the HIV epidemic.

PrEP is more than just a drug; it is a symbol of progress in the fight against HIV and AIDS. With its potential to save lives and transform communities, PrEP has become an essential component of HIV prevention strategies worldwide. The introduction of the injectable version opens new doors and offers people more choices in how they want to protect themselves. Together, we can strive for a future where HIV no longer writes a new chapter, but remains a history lesson.

Related STD self-recall tests